Condition: Diabetic Macular Edema · Visual Impairment · Diabetes Mellitus · Sponsor: Vastra Gotaland Region
This study aims to investigate the association between serum biomarkers and clinical response to anti-VEGF or dexamethasone implant by assessing OCT-biomarkers in patients with diabetic macular edema, DME, and to compare these with a group of naive patients (those not previously treated for DME).
This description comes directly from the study's public registry record.
Imadeddin Abu Ishkheidem, M.D. · +46738744867 · imadeddin.abu.ishkheidem@vgregion.se
Sofia Töyrä Silfverswärd, PhD · 0761283085 · sofia.toyra.silfversward@vgregion.se
Always discuss trial participation with your own doctor first.
| Sahlgrenska University Hospital, Department of Ophthalmology | Mölndal, Sweden | Recruiting |
| Ögonmottagning Mölndal/SU | Mölndal, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06984822